John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Allegiant Air
ALGT
$2.23B
| $1.13M | 0.01% |
+5,890
| New | +$1.06M |
|
|
BCIC
1502
BCP Investment Corp
BCIC
$94.9M
| $1.13M | 0.01% |
16,797
-13,766
| -45% | -$964K |
|
|
USAK
1503
DELISTED
USA Truck Inc
USAK
| $1.13M | 0.01% |
40,793
+21,560
| +112% | +$623K |
|
1504
Griffon
GFF
$4.59B
| $1.13M | 0.01% |
64,761
-52,530
| -45% | -$809K |
|
1505
PUT
Murphy Oil
MUR
$5.16B
| $1.13M | 0.01% |
+24,200
| New | +$1.17M |
|
1506
CALL
Northrop Grumman
NOC
$78B
| $1.13M | 0.01% |
+7,000
| New | +$1.12M |
|
|
VRN
1507
DELISTED
Veren
VRN
| $1.13M | 0.01% |
51,937
+3,339
| +7% | +$76.1K |
|
1508
PUT
Amgen
AMGN
$240B
| $1.12M | 0.01% |
+7,000
| New | +$1.1M |
|
1509
PUT
Genuine Parts
GPC
$18.7B
| $1.12M | 0.01% |
+12,000
| New | +$1.16M |
|
|
ESV
1510
PUT
DELISTED
Ensco Rowan plc
ESV
| $1.12M | 0.01% |
+13,250
| New | +$1.4M |
|
|
CKEC
1511
DELISTED
Carmike Cinemas Inc
CKEC
| $1.12M | 0.01% |
33,233
+23,258
| +233% | +$691K |
|
1512
MiMedx Group
MDXG
$622M
| $1.11M | 0.01% |
107,020
-7,933
| -7% | -$74.2K |
|
1513
PUT
Suncor Energy
SU
$78.8B
| $1.11M | 0.01% |
+38,000
| New | +$1.13M |
|
1514
WSFS Financial
WSFS
$4.06B
| $1.11M | 0.01% |
43,971
+19,461
| +79% | +$496K |
|
|
FPRX
1515
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.11M | 0.01% |
+48,448
| New | +$1.22M |
|
|
ATRI
1516
DELISTED
Atrion Corp
ATRI
| $1.11M | 0.01% |
3,200
+1,808
| +130% | +$603K |
|
1517
Mastercard
MA
$525B
| $1.1M | 0.01% |
12,767
-995,697
| -99% | -$86.4M |
|
1518
PUT
NOV
NOV
$7.04B
| $1.1M | 0.01% |
+22,000
| New | +$1.19M |
|
|
OME
1519
DELISTED
Omega Protein
OME
| $1.1M | 0.01% |
80,186
+40,235
| +101% | +$464K |
|
|
BPFH
1520
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $1.1M | 0.01% |
90,277
-157,971
| -64% | -$1.94M |
|
|
XEC
1521
DELISTED
CIMAREX ENERGY CO
XEC
| $1.1M | 0.01% |
9,520
-11,438
| -55% | -$1.23M |
|
|
PBY
1522
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
| $1.09M | 0.01% |
113,809
-5,591
| -5% | -$51K |
|
1523
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.82B
| $1.09M | 0.01% |
49,200
+22,800
| +86% | +$502K |
|
|
HES
1524
PUT
DELISTED
Hess
HES
| $1.09M | 0.01% |
+16,000
| New | +$1.14M |
|
|
MODN
1525
DELISTED
MODEL N, INC.
MODN
| $1.08M | 0.01% |
90,502
-18,865
| -17% | -$217K |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.